Omnicare: Advanced Care Scripts to Provide Specialty Pharmacy Services for Otezla® (apremilast) ORLANDO, June 11, 2014 - Advanced Care Scripts (ACS), a division of Omnicare Specialty Care Group (SCG), announced today that it has been added to the limited distribution network for Celgene's Otezla^® (apremilast). Otezlais indicated for the treatment of adult patients with active psoriatic arthritis. Otezla can help reduce symptoms of psoriatic arthritis such as joint swelling and tenderness, and joint pain. Otezla is the first FDA approved oral therapy for this condition. ACS has proven experience in successfully managing and dispensing specialty medications, making us an ideal partner for Celgene and distributor of Otezla. Our expertise providing access and reimbursement support allows us to help navigate insurance benefits and find available financial assistance for patients. ACS' services are coordinated to simplify the reimbursement and delivery of biotech therapies used to treat numerous disease states, including chronic inflammatory diseases, auto-immune disorders, cancer, infectious diseases, multiple sclerosis and hemophilia. "Early detection and treatment of psoriatic arthritis is crucial, and we are proud to play a role in helping patients achieve access to Otezla," said Amit Jain, Senior Vice President of Sales and Marketing. "ACS is pleased to partner with Celgene to dispense this new oral treatment option, which can help reduce symptoms and improve physical functioning in patients with this condition." About Omnicare Specialty Care Group Omnicare Specialty Care Group (SCG) is a division of Omnicare, Inc., a Fortune 500 company and provider of comprehensive pharmaceutical services based in Cincinnati, Ohio. Omnicare SCG is a combination of synergistic tenured companies with a focused approach to pharmaceutical brand solutions. Together, Omnicare SCG brings specialists in reimbursement methods, clinicians practiced in medication therapy management for chronic disease states, and distribution channel expertise. Solutions are tailored to drive product access by solving challenges faced by patients and their caregivers, physicians, payers and manufacturers. Custom programs are led by a single management team across the organizational platforms, allowing coordination of resources and assets to support positive outcomes for our patients. For more information, visit www.omnicarescg.com. About Advanced Care Scripts Advanced Care Scripts, a specialty pharmacy, manages and dispenses specialty medications and products nationwide. It coordinates services beginning with the prescriber to simplify reimbursement and delivery of biotech therapies used to treat cancer, infectious diseases, auto-immune disorders, multiple sclerosis, hemophilia, and other disease states. Its customer service and comprehensive patient care model provides compliance and adherence support and cost-effective solutions for all classes of specialty medications. # # # Contacts: Media/Investors: Patrick C. Lee (513) 719-1507 firstname.lastname@example.org Business: Amit Jain (859) 547-6245 email@example.com ------------------------------------------------------------------------------ This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Omnicare via Globenewswire HUG#1791908
Omnicare: Advanced Care Scripts to Provide Specialty Pharmacy Services for Otezla® (apremilast)
Press spacebar to pause and continue. Press esc to stop.